Boehringer Ingelheim FENS Award for exceptional research in neuroscience
- Details
- Category: Boehringer Ingelheim
The 2008 Boehringer Ingelheim FENS Research Award goes to Pascal Fries, MD, PhD, from the F.C. Donders Centre for Cognitive Neuroimaging in Nijmegen, The Netherlands. At the Congress of the Federation of European Neuroscience Societies (FENS) taking place from 12-16 July 2008 in Geneva, on the occasion of a special lecture by the prize winner, the Boehringer Ingelheim FENS Research Award will be presented for the fourth time.
Novartis completes acquisition of 25% stake in Alcon from Nestlé
- Details
- Category: Novartis
Novartis has acquired a 25% stake in Alcon Inc. (NYSE: ACL) as part of a definitive agreement with Nestlé S.A. reached in April 2008 that provides the right to acquire majority ownership of the world leader in eye care in two steps.
Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
- Details
- Category: Pfizer
Pfizer announced that new statin users who took Lipitor® (atorvastatin calcium) were significantly more likely to stay on their medication compared to those who took simvastatin, according to an observational study of more than 186,000 patients in one of the largest U.S. managed care claims databases. The results were published in the July issue of Current Medical Research and Opinion.
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
- Details
- Category: Novartis
Novartis Pharmaceuticals Corporation (NPC) announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system.
Shire proposes acquisition of Jerini AG for an equity purchase price of €328 million
- Details
- Category: Shire
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that Maia Elfte Vermögensverwaltungs-GmbH, to be renamed "Shire Deutschland Investments GmbH", a German indirect subsidiary of Shire Limited, will launch a voluntary public takeover offer for shares in Jerini AG (FSE:JI4, ISIN: DE0006787476), the publicly listed German biotechnology company.
Summary Judgment Granted for SEROQUEL Patent Litigation in the US
- Details
- Category: AstraZeneca
AstraZeneca announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs).
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of Cervarix®, its vaccine to prevent cervical cancer.
More Pharma News ...
- Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development
- Roche's tender offer to increase ownership stake in Chugai successful
- Abbott and Partnership for a Drug-Free America Launch 'Not In My House'
- Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United Stat
- Cervarixâ¢, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme
- Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
- Genzyme Files Applications for Approval of Mozobil in the United States and Europe